RPD and Higher Risk of Progression to Late AMD

February 2023 Youning Zhang, MD Location/Affiliation: Los Angeles, Olive View – UCLA Medical Center Agron E, Domalpally A, Cukras C, Clemons TE, Chen Q, Lu Z, Chew EY, Keenan TDL, for the AREDS and AREDS2 Research Group. Ophthalmology 2022;129:1107-1119. Reticular Pseudodrusen: The Third Macular Risk Feature for Progression to Late Age-Related Macular Degeneration. doi: 10.1016/j.ophtha.2022.05.021. […]

Optimal Timing for RRD Repair

February 2023 Written by: Monique Munro, MD, FRCSC Locum with University of Calgary, Section of Ophthalmology Calgary, AB, Canada Sothivannan A, Eshtiaghi A, Dhoot AS, Popovic MM, Garg SJ, Kertes PJ, Muni RH. Impact of the Time to Surgery on Visual Outcomes for Rhegmatogenous Retinal Detachment Repair: A Meta-Analysis. Am J Ophthalmol. 2022 Dec;244:19-29.  Visual […]

Air Versus Gas Tamponade for Small- and Medium-Sized Macular Holes

February 2023 Written by: Wasim Samara, MD Taylor Retina Center Raleigh, NC Lindtjørn B, Krohn J, Haugstad M, Stene-Johansen I, Austeng D, Basit S, Fossen K, Varhaug P, Kvaløy JT, Forsaa VA. Air versus Sulfur Hexafluoride Gas Tamponade for Small and Medium-Sized Macular Holes: A Randomized Noninferiority Trial. Ophthalmol Retina. 2022 Sep;6(9):828-834. doi: 10.1016/j.oret.2022.04.003. Epub […]

Drainage Retinotomy is a Risk Factor for Surgical Failure after Pars Plana Vitrectomy in Patients with Primary Uncomplicated Rhegmatogenous Retinal Detachment

January 2023 Written by: Tamara Lee Lenis, MD PhD NJ Retina Ohara H, Yuasa Y, Harada Y, Hiyama T, Sadahide A, Minamoto A, Hirooka K, Kiuchi Y. DRAINAGE RETINOTOMY IS A RISK FACTOR FOR SURGICAL FAILURE AFTER PARS PLANA VITRECTOMY IN PATIENTS WITH PRIMARY UNCOMPLICATED RHEGMATOGENOUS RETINAL DETACHMENT. Retina. 2022 Dec 1;42(12):2307-2314. doi: 10.1097/IAE.0000000000003608. PMID: […]

Evaluation of Subretinal fluid Drainage Techniques During Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detachment – ELLIPSOID Study

January 2023 Written by:  Priya Vakharia, MD Retina Vitreous Associates of Florida Tampa Bay, FL McKay BR, Bansal A, Kryshtalskyj M, Wong DT, Berger A, Muni RH. Evaluation of Subretinal fluid Drainage Techniques During Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detachment-ELLIPSOID Study. Am J Ophthalmol. 2022 Sep;241:227-237. doi: 10.1016/j.ajo.2022.05.008. Epub 2022 May 18. PMID: 35597323. This […]

Gas Tamponade for the Prevention of Postoperative Vitreous Hemorrhaging After Diabetic Vitrectomy: A Randomized Clinical Trial

December 2022 Written by:  Jordan Deaner, MD Mid Atlantic Retina / Wills Eye Hospital Philadelphia, PA Rush RB, Velazquez JC, Rosales CR, Rush SW. Gas Tamponade for the Prevention of Postoperative Vitreous Hemorrhaging After Diabetic Vitrectomy: A Randomized Clinical Trial. Am J Ophthalmol. 2022;242:173-180. doi:10.1016/j.ajo.2022.06.015 Disclosures: EyePoint – Consultant, Alimera – Consultant Vitreous hemorrhage (VH) […]

Efficacy and Safety of Biosimilar FYB201 Compared With Ranibizumab in Neovascular Age-Related Macular Degeneration

December 2022 Written by:  Jordan Deaner, MD Mid Atlantic Retina / Wills Eye Hospital Philadelphia, PA Holz FG, Oleksy P, Ricci F, et al. Efficacy and safety of biosimilar FYB201 compared with ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2022;129(1):54-63.   Recently the United States Food and Drug Administration (USFDA) approved the first interchangeable biosimilar for use […]

OCT Risk Factors for Development of Atrophy in Eyes with Intermediate Age-Related Macular Degeneration

November 2022 Written by:  Katherine E. Talcott, MD Cole Eye Institute / Cleveland Clinic Hirabayashi K, Yu HJ, Wakatsuki Y, Marion KM, Wykoff CC, Sadda SR. OCT risk factors for development of atrophy in eyes with intermediate age-related macular degeneration. Ophthalmol Retina. 2022;6;S2468-6530(22)00486-9. doi 10.1016/j.oret.2022.09.007. Online ahead of print. While treatments for atrophic age-related macular […]